Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
SUR mutation in type 1 diabete...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group
Bibliographic Details
Main Authors:
Porksen, S
,
Laborie, L
,
Nielsen, L
,
De Wet, H
,
Schvarcz, E
,
Sandal, T
,
Aman, J
,
Swift, P
,
Hougaard, P
,
Ashcroft, F
,
Molven, A
,
Knip, M
,
Hansen, L
,
Njolstad, P
,
Mortensen, H
Format:
Conference item
Published:
2008
Holdings
Description
Similar Items
Staff View
Similar Items
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
by: Pörksen, S, et al.
Published: (2010)
Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
by: Tammaro, P, et al.
Published: (2005)
Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
by: Proks, P, et al.
Published: (2006)
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
by: Pearson, E, et al.
Published: (2006)
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
by: Sagen, J, et al.
Published: (2004)